DSpace university logo mark
Advanced Search
Japanese | English 

NAOSITE : Nagasaki University's Academic Output SITE > School of Medicine > Bulletin > Acta Medica Nagasakiensia > Volume 60, No. 2 >

A modified application of the luciferase immunoprecipitation systems for detecting antibodies to the G protein-coupled receptors

File Description SizeFormat
ActMed60_69.pdf2.02 MBAdobe PDFView/Open

Title: A modified application of the luciferase immunoprecipitation systems for detecting antibodies to the G protein-coupled receptors
Authors: Mukaino, Akihiro / Higuchi, Osamu / Nakane, Shunya / Maeda, Yasuhiro / Sakai, Waka / Nakamura, Hideki / Matsuo, Hidenori / Kawakami, Atsushi
Issue Date: Jan-2016
Publisher: Nagasaki University School of Medicine / 長崎大学医学部
Citation: Acta medica Nagasakiensia, 60(2), pp.69-76; 2016
Abstract: Background: When multipass transmembrane molecules are located on the cell surface, there may be interaction with not only bioactive molecules but also pathogenic molecules in areas protruding outside the cell. In antibody-mediated autoimmune disorders, it has been found that the autoantibodies occasionally attack membrane molecules on the cell surface, thus causing the disease such as myasthenia gravis. In such cases, highly sensitive autoantibody detection technology is required for early diagnosis. However, autoantibody analysis technology that is specialized for membrane molecules is still under development. Here we demonstrate a novel method for detecting of antibodies against the extracellular portions of multipass transmembrane molecules. Methods: Antibodies for muscarinic acetylcholine receptor type3 (M3R) were detected with two kinds of luciferase immunoprecipitaion systems (LIPS), conventional LIPS (cLIPS) and its modified application, termed modified LIPS (mLIPS). In mLIPS, antibodies against extracellular portions of membrane molecules could be preferentially detected. Results: An antibody to the amino-terminal portion of human M3R was detected with modified LIPS with a high sensitivity. In contrast, an antibody to the carboxyl-terminal portion was not detected with mLIPS, because it did not interact with intracellular portions of M3R in living cells. We also found antibodies for M3R in a patient serum with Sjögren’s syndrome. Conclusion: Our technology has a promising future, and we hope that it will be applied in the analysis of antibodies against a diverse range of multipass transmembrane molecules, including GPCRs.
Keywords: GPCR / LIPS / AChR / luciferase / autoantibody / autoimmune disease
URI: http://hdl.handle.net/10069/36171
ISSN: 00016055
Type: Departmental Bulletin Paper
Text Version: publisher
Appears in Collections:Volume 60, No. 2

Citable URI : http://hdl.handle.net/10069/36171

All items in NAOSITE are protected by copyright, with all rights reserved.


Valid XHTML 1.0! Copyright © 2006-2015 Nagasaki University Library - Feedback Powerd by DSpace